Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$454.38 USD

454.38
833,265

+5.44 (1.21%)

Updated Aug 7, 2025 03:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Nalak Das headshot

5 Corporate Giants Set to Win Big on Q2 Earnings This Week

by Nalak Das

Second-quarter 2019 earnings results so far are not as disappointing as expected initially. However, the forecast of overall earnings dip for two consecutive quarters is still looming large.

Zacks Equity Research

What to Expect From Cypress Semiconductor's (CY) Q2 Earnings

by Zacks Equity Research

Cypress Semiconductor's (CY) Q2 earnings are likely to be driven by growth in automotive, IoT & USB-C solutions. Yet, ongoing trade tensions & weak macro environment might affect its upcoming results.

Zacks Equity Research

Fortive (FTV) Gears Up for Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Fortive's (FTV) second-quarter results are likely to benefit from strong product portfolio and healthy contribution from acquisitions. However, end-market cyclicality might impact its earnings.

Zacks Equity Research

Atlassian (TEAM) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Atlassian's (TEAM) Q4 results are likely to benefit from strong growth in subscription revenues.

Zacks Equity Research

Will LabCorp's (LH) Q2 Earnings Gain From Overall Growth?

by Zacks Equity Research

Within Covance Drug Development, LabCorp (LH) is focused on driving profitable growth through expanded solutions and enhanced operational capabilities.

Swarup Gupta headshot

These $100B+ Stocks are Must-Buys Ahead of Q2 Earnings

by Swarup Gupta

Several sector bellwethers are projected to outperform their earnings estimates this week.

Zacks Equity Research

What's in Store for STMicroelectronics' (STM) Q2 Earnings?

by Zacks Equity Research

STMicroelectronics' (STM) Q2 results are likely to gain from robust products & solid execution. Uncertainty in some of the end-markets served and the ongoing U.S.-China trade war pose serious threats.

Zacks Equity Research

What's in the Offing for Alphabet's (GOOGL) Q2 Earnings?

by Zacks Equity Research

Alphabet's (GOOGL) focus on artificial intelligence and cloud is likely to boost second-quarter results. However, higher expenses and litigation charges are headwinds.

Zacks Equity Research

Analytical Instruments to Aid Thermo Fisher (TMO) Q2 Earnings?

by Zacks Equity Research

Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher's (TMO) analytical instruments revenues.

Zacks Equity Research

PayPal (PYPL) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

PayPal's (PYPL) second-quarter results are likely to benefit from strong product portfolio and strategic partnerships.

Zacks Equity Research

ASGN to Report Q2 Earnings: What's in Store for the Stock?

by Zacks Equity Research

ASGN's second-quarter results are likely to be perked up by broad-based segmental growth.

Zacks Equity Research

F5 Networks (FFIV) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Growth in software solutions is likely to aid F5 Networks' (FFIV) third-quarter fiscal 2019 results. However, slowdown in systems business is a persistent downside.

Zacks Equity Research

TE Connectivity (TEL) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

TE Connectivity's (TEL) industrial and communications solutions portfolio is likely to aid fiscal Q3 results. Yet, weak market conditions in China & softness in European Auto may mar top-line growth.

Zacks Equity Research

Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?

by Zacks Equity Research

Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.

Trina Mukherjee headshot

IVD Market Sustains Momentum: 3 Stocks in Focus

by Trina Mukherjee

In-vitro Diagnostics has successfully proven itself to be the best diagnostic procedures. So, investors can add stocks from this space to their watchlist.

Zacks Equity Research

Can Product Strength Aid Texas Instruments (TXN) Q2 Earnings?

by Zacks Equity Research

We do not expect Texas Instruments (TXN) to perform well in Q2 owing to weakness in demand and an uncertain macro environment. However, strength in analog & embedded markets might aid results.

Zacks Equity Research

Abbott (ABT) Tops Q2 Earnings Estimates, Lifts EPS Guidance

by Zacks Equity Research

Abbott (ABT) registers strong Cardiovascular and Neuromodulation sales on double-digit growth in Electrophysiology, Heart Failure and Structural Heart.

Zacks Equity Research

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?

by Zacks Equity Research

Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME

Nalak Das headshot

Can Fed Put Counter Potential Negative Q2 Earnings? 5 Picks

by Nalak Das

Fed's rate cut will not only make cheaper funds available to businesses and stock market investors, but also U.S. dollar less expensive in the international market.

Zacks Equity Research

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

The Zacks Analyst Blog Highlights: JPMorgan, Thermo Fisher, Broadcom, Marriott and Global Payments

by Zacks Equity Research

The Zacks Analyst Blog Highlights: JPMorgan, Thermo Fisher, Broadcom, Marriott and Global Payments

Mark Vickery headshot

Top Stock Reports for JPMorgan, Thermo Fisher & Broadcom

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Thermo Fisher (TMO) and Broadcom (AVGO).

Zacks Equity Research

Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics

by Zacks Equity Research

The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.